Evaluation of 2016 MAGNIMS MRI criteria for dissemination in space in patients with a clinically isolated syndrome

Jae Won Hyun, So Young Huh, Woojun Kim, Min Su Park, Suk Won Ahn, Joong Yang Cho, Byung Jo Kim, Sang Hyun Lee, Su Hyun Kim, Ho Jin Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: We compared validity of 2010 McDonald and newly proposed 2016 Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) criteria for dissemination in space (DIS) in predicting the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndrome (CIS). Methods: Between 2006 and 2016, we enrolled 170 patients who had a first clinical event suggestive of multiple sclerosis (MS) from seven referral hospitals in Korea. Patients were classified into two groups based on the main outcome at the last follow-up: CDMS converters, who experienced a second attack, and non-converters. Results: Of 170 patients with mean follow-up duration of 54 months, 51% converted to CDMS. The sensitivity, specificity, accuracy, and positive and negative predictive values of 2010 McDonald criteria were 70.9%, 63.1%, 67.1%, 66.3%, and 67.9%, and those for 2016 MAGNIMS criteria were 88.4%, 46.4%, 67.7%, 62.8%, and 79.6%, respectively. When we excluded 80 patients who underwent disease-modifying therapy before the second clinical event, the specificity increased to 92.3% and 84.6%, but the sensitivity decreased to 58.8% and 82.4% for 2010 McDonald and 2016 MAGNIMS criteria, respectively. Conclusion: 2016 MAGNIMS magnetic resonance imaging (MRI) criteria for DIS showed higher sensitivity but lower specificity than 2010 McDonald criteria in predicting conversion to CDMS in CIS patients.

Original languageEnglish
JournalMultiple Sclerosis Journal
DOIs
Publication statusAccepted/In press - 2017 May 1

Fingerprint

Multiple Sclerosis
Magnetic Resonance Imaging
Sensitivity and Specificity
Korea
Referral and Consultation

Keywords

  • diagnosis
  • MRI
  • Multiple sclerosis

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Evaluation of 2016 MAGNIMS MRI criteria for dissemination in space in patients with a clinically isolated syndrome. / Hyun, Jae Won; Huh, So Young; Kim, Woojun; Park, Min Su; Ahn, Suk Won; Cho, Joong Yang; Kim, Byung Jo; Lee, Sang Hyun; Kim, Su Hyun; Kim, Ho Jin.

In: Multiple Sclerosis Journal, 01.05.2017.

Research output: Contribution to journalArticle

Hyun, Jae Won ; Huh, So Young ; Kim, Woojun ; Park, Min Su ; Ahn, Suk Won ; Cho, Joong Yang ; Kim, Byung Jo ; Lee, Sang Hyun ; Kim, Su Hyun ; Kim, Ho Jin. / Evaluation of 2016 MAGNIMS MRI criteria for dissemination in space in patients with a clinically isolated syndrome. In: Multiple Sclerosis Journal. 2017.
@article{4d10df767b594d9ebdc94029c1c3aa56,
title = "Evaluation of 2016 MAGNIMS MRI criteria for dissemination in space in patients with a clinically isolated syndrome",
abstract = "Objectives: We compared validity of 2010 McDonald and newly proposed 2016 Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) criteria for dissemination in space (DIS) in predicting the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndrome (CIS). Methods: Between 2006 and 2016, we enrolled 170 patients who had a first clinical event suggestive of multiple sclerosis (MS) from seven referral hospitals in Korea. Patients were classified into two groups based on the main outcome at the last follow-up: CDMS converters, who experienced a second attack, and non-converters. Results: Of 170 patients with mean follow-up duration of 54 months, 51{\%} converted to CDMS. The sensitivity, specificity, accuracy, and positive and negative predictive values of 2010 McDonald criteria were 70.9{\%}, 63.1{\%}, 67.1{\%}, 66.3{\%}, and 67.9{\%}, and those for 2016 MAGNIMS criteria were 88.4{\%}, 46.4{\%}, 67.7{\%}, 62.8{\%}, and 79.6{\%}, respectively. When we excluded 80 patients who underwent disease-modifying therapy before the second clinical event, the specificity increased to 92.3{\%} and 84.6{\%}, but the sensitivity decreased to 58.8{\%} and 82.4{\%} for 2010 McDonald and 2016 MAGNIMS criteria, respectively. Conclusion: 2016 MAGNIMS magnetic resonance imaging (MRI) criteria for DIS showed higher sensitivity but lower specificity than 2010 McDonald criteria in predicting conversion to CDMS in CIS patients.",
keywords = "diagnosis, MRI, Multiple sclerosis",
author = "Hyun, {Jae Won} and Huh, {So Young} and Woojun Kim and Park, {Min Su} and Ahn, {Suk Won} and Cho, {Joong Yang} and Kim, {Byung Jo} and Lee, {Sang Hyun} and Kim, {Su Hyun} and Kim, {Ho Jin}",
year = "2017",
month = "5",
day = "1",
doi = "10.1177/1352458517706744",
language = "English",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - Evaluation of 2016 MAGNIMS MRI criteria for dissemination in space in patients with a clinically isolated syndrome

AU - Hyun, Jae Won

AU - Huh, So Young

AU - Kim, Woojun

AU - Park, Min Su

AU - Ahn, Suk Won

AU - Cho, Joong Yang

AU - Kim, Byung Jo

AU - Lee, Sang Hyun

AU - Kim, Su Hyun

AU - Kim, Ho Jin

PY - 2017/5/1

Y1 - 2017/5/1

N2 - Objectives: We compared validity of 2010 McDonald and newly proposed 2016 Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) criteria for dissemination in space (DIS) in predicting the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndrome (CIS). Methods: Between 2006 and 2016, we enrolled 170 patients who had a first clinical event suggestive of multiple sclerosis (MS) from seven referral hospitals in Korea. Patients were classified into two groups based on the main outcome at the last follow-up: CDMS converters, who experienced a second attack, and non-converters. Results: Of 170 patients with mean follow-up duration of 54 months, 51% converted to CDMS. The sensitivity, specificity, accuracy, and positive and negative predictive values of 2010 McDonald criteria were 70.9%, 63.1%, 67.1%, 66.3%, and 67.9%, and those for 2016 MAGNIMS criteria were 88.4%, 46.4%, 67.7%, 62.8%, and 79.6%, respectively. When we excluded 80 patients who underwent disease-modifying therapy before the second clinical event, the specificity increased to 92.3% and 84.6%, but the sensitivity decreased to 58.8% and 82.4% for 2010 McDonald and 2016 MAGNIMS criteria, respectively. Conclusion: 2016 MAGNIMS magnetic resonance imaging (MRI) criteria for DIS showed higher sensitivity but lower specificity than 2010 McDonald criteria in predicting conversion to CDMS in CIS patients.

AB - Objectives: We compared validity of 2010 McDonald and newly proposed 2016 Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) criteria for dissemination in space (DIS) in predicting the conversion to clinically definite multiple sclerosis (CDMS) in patients with clinically isolated syndrome (CIS). Methods: Between 2006 and 2016, we enrolled 170 patients who had a first clinical event suggestive of multiple sclerosis (MS) from seven referral hospitals in Korea. Patients were classified into two groups based on the main outcome at the last follow-up: CDMS converters, who experienced a second attack, and non-converters. Results: Of 170 patients with mean follow-up duration of 54 months, 51% converted to CDMS. The sensitivity, specificity, accuracy, and positive and negative predictive values of 2010 McDonald criteria were 70.9%, 63.1%, 67.1%, 66.3%, and 67.9%, and those for 2016 MAGNIMS criteria were 88.4%, 46.4%, 67.7%, 62.8%, and 79.6%, respectively. When we excluded 80 patients who underwent disease-modifying therapy before the second clinical event, the specificity increased to 92.3% and 84.6%, but the sensitivity decreased to 58.8% and 82.4% for 2010 McDonald and 2016 MAGNIMS criteria, respectively. Conclusion: 2016 MAGNIMS magnetic resonance imaging (MRI) criteria for DIS showed higher sensitivity but lower specificity than 2010 McDonald criteria in predicting conversion to CDMS in CIS patients.

KW - diagnosis

KW - MRI

KW - Multiple sclerosis

UR - http://www.scopus.com/inward/record.url?scp=85041782848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041782848&partnerID=8YFLogxK

U2 - 10.1177/1352458517706744

DO - 10.1177/1352458517706744

M3 - Article

AN - SCOPUS:85041782848

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

ER -